Granules India receives EIR report for Granules Pharmaceuticals Inc. facility in Virginia

Granules India announced that USFDA has issued Establishment Inspection Report for Granules Pharmaceuticals Inc. facility a wholly foreign subsidiary of the company located in Chantilly, Virginia, USFDA

This facility was inspected by USFDA in December 2017 and there was one observation during the inspection. The company has responded to the observation within the stipulated timeframe.

Powered by Capital Market - Live News